Search Results 1891-1900 of 16151 for Epilepsy (Partial Onset)

1. Publications - Ali A. Duarte Garcia, M.D. - Mayo Clinic

   Epidemiology of Childhood-Onset Systemic Lupus Erythematosus: A Population-Based Study. Arthritis Care Res (Hoboken). 2022 May; 74 (5):728-732 Epub 2022 Feb ...

2. Neurology - Doctors - Mayo Clinic

   ted disease, Paraneoplastic syndromes of the nervous system, Autoimmune disease, Autoimmune epilepsy. Show more areas of focus for Sean J. Pittock, M.D. ...

3. Neurology - Doctors - Mayo Clinic

   , Autoimmune encephalitis, Cerebrovascular disease, Seizure , Encephalitis, Autoimmune disease. Show more areas of focus for Molly G. Knox, M.D.. Pagination ...

4. Migraine Clinical Trials - Mayo Clinic Research

   The purpose of this study is to predict migraine headache onset from changes in speech in people who have a history of migraines. ... onset premonitory changes ...

5. A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   Documented ALS history of location of disease onset (i.e., bulbar onset, limb onset). A total ALSFRS-R score of at least 35 overall at screening and: No ...

6. A Study to Evaluate the Effectiveness and Safety of rAd-IFN Administered With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma - Mayo Clinic

   International normalized ratio (INR) and activated partial thromboplastin time (aPTT) below the upper limit of normal (ULN). It is expected that patients ...

7. Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator - Mayo Clinic

   ... duration on the qualifying ECG >90 msec); Passing S-ICD Screening ECG performed per applicable user's manual on or after the consent date that identifies one ...

8. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   During the early phases (phases 1 and 2) ... Known CNS metastases or seizure disorder. Patients with ... seizure activity will be eligible. Any of the ...

9. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... Patients under guardianship or partial ... epileptic therapy are allowed.

10. ABT-888 With Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Negative Breast Cancer, and Low-Grade Non-Hodgkin's Lymphoma - Mayo Clinic

    Patients with history of CNS metastases who have received treatment and who have been on stable doses of anti-seizure medicine and had no seizures x 3 months ...